4.0 Article

Is it time to routinely incorporate MRD into practice?

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.beha.2018.09.013

关键词

Acute myeloid leukemia; AML; Assay; MFC; Multi-parameter flow cytometry; Minimal/measurable residual disease; MRD; Next-generation sequencing; NGS; Reverse-transcriptase-polymerase-chain reaction; RT-PCR

向作者/读者索取更多资源

Interest in detecting minimal/measurable residual disease (MRD) in acute myeloid leukemia (AML) has been increasing, but numerous issues need to be addressed if MRD assessment is to be routinely incorporated into practice. Assays, their reliability, standardization, and availability all must be considered, and a strategy developed to eradicate residual leukemia. This paper reviews some issues surrounding the routine incorporation of MRD assessment into practice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据